Toby Eyre
@tobyeyre82
Followers
10K
Following
9K
Media
753
Statuses
4K
Lymphoma & CLL specialist @OUHospitals
Churchill Cancer Centre,Oxford
Joined April 2018
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† - Annals of Oncology
annalsofoncology.org
The treatment landscape for many lymphoma entities continues to evolve rapidly, with multiple recent approvals of novel non-chemotherapy (ChT)-based approaches. The following Clinical Practice...
4
43
112
On Fonzi, you don’t chase jobs, the best AI startups and tech companies come to you.
0
2
19
Great to have the fantastic Beth Phillips speak on the challenging area of relapsed Hodgkin and @CwynKate give a masterful overview of T-cell lymphoma. Wish you had signed up? You still can! And hear all the talks / Q&A on playback. Don’t miss it!
Week 2 of #LymphomaManagement kicks off tonight, continuing our engaging programme for healthcare professionals working in #Lymphoma. Booking is still open 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @OxfordHaem #LymSM
2
2
7
First-line acalabrutinib-obinutuzumab resulted in significantly higher PFS and OS than chemoimmunotherapy regardless of high-risk features. https://t.co/5juz6iW7f6
#clinicaltrialsandobservations #lymphoidneoplasia
0
10
43
Still not too late to register. You can watch each session back on demand. Week 2 starts tonight 7pm UK time. #lymphoma #lymsm
We are off! Week 1 tonight - still not too late to sign up. #Lymphoma #Lymsm @LymphomaAction
https://t.co/ZH1yKbBAiV
1
0
2
Did you know GSPs are natural swimmers? They’re born to dive into life’s adventures 🌊🐾.
19
51
1K
Hear about post-transplant lymphoproliferative disorder from Dr Sridhar Chaganti at #LymphomaManagement, our online course for healthcare professionals in #Lymphoma. We are now on Week 2! Book now 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @SridharChaganti #LymSM
0
1
3
🙌🙌 We are pleased to announce the appointment of 3 new Associate Editors for the @BrJHaem: 1) Dr Andrea Kuhnl @KingsCollegeNHS (#CART, #lymphoma) 🇬🇧 2) Dr Maria-Victoria Mateos @mvmateos @usal (#myeloma) 🇪🇸 3) Dr Josep-Maria Ribera @hgermanstrias (acute #leukemia) 🇪🇸
2
11
63
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
ashpublications.org
Key Points. Fixed-duration epcoritamab plus R2 showed deep, durable responses with favorable long-term outcomes in R/R FL regardless of risk featuresEpcori
0
4
23
Thank you for joining Week 1 of #LymphomaManagement! Covering High-grade non-Hodgkin #Lymphoma: diagnostics and #DLBCL, it was an evening of expertise shared! You can still book to join us for the rest of the course 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM
0
4
4
The moments keep coming. Make the most of every play and show them something they'll never forget in NBA 2K26. Early Access Starts 8/29. Powered by @nba2k
2
1
15
We are off! Week 1 tonight - still not too late to sign up. #Lymphoma #Lymsm @LymphomaAction
https://t.co/ZH1yKbBAiV
1
6
16
The online #LymphomaManagement course starts tonight! We are excited to bring healthcare professionals a programme of expert speakers in #Lymphoma to refine and refresh your knowledge. Booking is still open 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @OxfordHaem #LymSM
0
3
5
#LymphomaManagement starts tonight! Professor Kate Cwynarski will cover Peripheral T-cell #Lymphoma during this online course for healthcare professionals. Still to book your place? Book now and don't miss out 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 @CwynKate #LymSM
0
1
9
Published in the BJHaem today. BSH GPP providing practical guidance to HCPs on administration and toxicity management of BsAb for lymphoma. https://t.co/QfCJtMAeor
1
13
36
Professor Andy Davies will discuss relapsed diffuse large B-cell lymphoma (#DLBCL) at #LymphomaManagement next week. If you're a healthcare professional working in #Lymphoma, book your place today 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM #Haematology
0
1
4
@LymphomaAction @tobyeyre82 Nearly time for the 2026 national lymphoma management course. Do make sure you have booked your place.
0
1
4
One week to go until #LymphomaManagement 2025! Hear from Dr Cathy Burton about why you don't want to miss out on this leading course for healthcare professionals working in #Lymphoma. Book your place 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM #Haematology
2
2
7
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
ashpublications.org
Key Points. The fitness status of patients with previously untreated CLL does not impair safety and efficacy of Ven-ObiVenetoclax dose reductions are more
0
1
16
Hear about nodular lymphocyte-predominant Hodgkin #Lymphoma (NLPHL) from Dr Pam McKay at #LymphomaManagement - our online course for healthcare professionals. Book your place today 👉 https://t.co/LvbNrNSxM8
@pammckay123 @graham74GC @tobyeyre82 @OxfordHaem #LymSM #Haematology
0
2
6
Want to know the latest updates in Richter's transformation? Including the recent ERIC recommendations and novel treatment strategies? Read our feature article: 👉 https://t.co/7CpKo1Sfy3👈 Featuring expert insights from @AdamKittai (@IcahnMountSinai) and @DrMDavids
1
3
8
#LymphomaManagement course directors Professor Graham Collins and Dr Toby Eyre set an engaging programme with an excellent faculty of expert speakers, on the management of #Lymphoma for healthcare professionals. Book now 👉 https://t.co/LvbNrNSxM8
@graham74GC @tobyeyre82 #LymSM
0
2
6